A compound having formula (I): wherein R1 is a saturated or unsaturated chain of 1-5 carbons in length; and R2 is a saturated or unsaturated chain of 3-10 carbons in length; and A is selected from the group consisting of COOL and CONR′—R″, wherein L is a lipid moiety selected from the group consisting of glycerol, C3-20 fatty acid monoglycerides, C3-20 fatty acid diglycerides, hydroxy-C2-6-alkyl esters of C3-20 fatty acids, hydroxy-C2-6-alkyl esters of lysophosphatidic acids, lyso plasmalogens, lysophospholipids, lysophosphatidic acid amides, glycerophosphoric acids, sphingolipids, lysophosphatidylethanolamines, and N-mono and N,N-di-(C1-4)alkyl derivatives of the amines thereof; and R′ and R″ are each independently selected from the group consisting of hydrogen and a lower alkyl group comprising 1-5 carbon atoms; and pharmaceutically acceptable salts thereof. In addition, there is provided methods for using these compositions.
化合物的
化学式为(I):其中R1是链长为1-5个碳原子的饱和或不饱和链;R2是链长为3-10个碳原子的饱和或不饱和链;A选自由COOL和CONR′—R″组成的群,其中L是从
甘油、C3-20
脂肪酸单
甘油酯、C3-20
脂肪酸二
甘油酯、C3-20
脂肪酸的羟基-C2-6烷基酯、溶血酯、溶血
磷脂、溶血
磷脂、
溶血磷脂酸酰胺、
甘油磷酸酸、鞘脂、溶血
磷酸酰
乙醇胺和其胺的N-单和N,N-二(C1-4)烷基衍
生物中选择的脂肪基;R′和R″各自独立地选自由氢和由1-5个碳原子组成的较低烷基基团;以及其药学上可接受的盐。此外,还提供了使用这些组合物的方法。